Compounds of the general formula (I)
and the physiologically acceptable solvates and cyclodextrin complexes thereof, in which
R¹ represents phenyl substituted by a group -NHCOR⁵ (where R5 is substituted phenyl);
A is -(CH₂)nX(CH₂)m- or -(CH₂)pS(O)q(CH₂)r- (where n is 1 or 2, m is 2-5 and X is cis or trans -CH=CH- or -CH₂CH₂- or m is 1-4 and X is -CH=C=CH-; p is 1-4, q is zero, 1 or 2 and r is 1-4);
Y is substituted or unsubstituted 3-phenoxy-2-hydroxypropyl.
These compounds inhibit gastric acid secretion and provide gastrointestinal cytoprotection and may be formulated for use in the treatment of ulcers. They may also be of use in the therapy or prophylaxis of atherosclerosis and other disorders associated with abnormal levels of blood lipids and serum chlolesterol.
通式(I)化合物
及其生理学上可接受的溶解物和
环糊精络合物,其中
R¹ 代表被基团 -NHCOR⁵ 取代的苯基(其中 R5 为取代的苯基);
A 是-(CH₂)nX(CH₂)m- 或-(CH₂)pS(O)q(CH₂)r-(其中 n 是 1 或 2,m 是 2-5,X 是顺式或反式-CH=CH- 或-CH₂CH₂-,或 m 是 1-4,X 是-CH=C=CH-;p 是 1-4,q 是零、1 或 2,r 是 1-4);
Y 是取代或未取代的 3-苯氧基-2-羟基丙基。
这些化合物可抑制胃酸分泌,提供胃肠道细胞保护,可配制成治疗溃疡的药物。它们还可用于治疗或预防动脉粥样硬化和其他与血脂和血清
胆固醇水平异常有关的疾病。